Utilization of Next-Generation Sequencing in Conjunction With Immunohistochemistry to Predict Exceptional Response to Combination Immune Checkpoint Therapy in a Heavily Pretreated Patient With Castration-Resistant Prostate Cancer.
Natalie M ReizineSamantha SoccoEric WengUka AtueyiVikas MehtaAkash PatnaikPublished in: JCO precision oncology (2023)